Harvard study involving Anthem unit finds older insulins are both safe, cheaper

With little fanfare, a private Medicare delivery system owned by Indianapolis-based insurer Anthem Inc. moved thousands of elderly patients with diabetes from costly new insulin drugs such as Sanofi’s Lantus to older and cheaper insulin products

View Article